Structural and biochemical changes in mitochondria after cisplatin treatment of Dalton's lymphoma-bearing mice

Mitochondrion

Volumn 10, Issue 1, 2010, Pages 38-45

  Prasad, Surya Bali ^a   Rosangkima, Gabriel ^a   Kharbangar, Arpaia ^a  

^a NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

Antitumor activity; Cisplatin; Glutathione; Mitochondria; Nephrotoxicity; Succinate dehydrogenase

Indexed keywords

CISPLATIN; GLUTATHIONE; MALONALDEHYDE; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; LIPID PEROXIDATION; LYMPHOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TOXICITY; MITOCHONDRION SWELLING; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SINGLE DRUG DOSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; KIDNEY; LIPID PEROXIDATION; LYMPHOMA; MICE; MITOCHONDRIA; PROTEINS; SUCCINATE DEHYDROGENASE;

MUS;

EID: 70450247129     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2009.09.002     Document Type: Article

References (81)

1. Abdullaev F.I. Cancer chemopreventive and tumoricidal properties of Saffron (Crocussativus L.). Exp. Biol. Med 227 (2002) 20-25
2. Alberts D.S., and Noel J.K. Cisplatin-associated neurotoxicity: can it be prevented?. Anti-cancer Drugs 6 (1995) 369-383
3. Appenroth D., Fröb S., Kersten L., Splinter F.K., and Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Archiv. Toxicol. 71 (1997) 677-683
4. 2+ by liver mitochondria. J. Biol. Chem. 259 (1984) 1279-1281
5. Beltrame M., Sindellari L., and Arslan P. Effects of newly synthesised platinum (II) complexes on mitochondrial functions. Chem. Biol. Interact. 50 (1984) 247-254
6. Brady H.R., Kone B.C., Stromski M.E., Zeidel M.L., Giebisch Gr., and Gullans S.R. Mitochondrial injury, an early event in cisplatin toxicity to renal proximal tubules. Am. J. Physiol. 258 (1990) 1181-1187
7. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52 (1978) 302-310
8. Catala A., Arcemis C., and Cerruti A. Interaction of rat liver microsomes saturated and unsaturated fatty acids with fatty acid binding protein: peroxidation effect. Mol. Cell Biochem. 137 (1994) 135-139
9. Cepeda V., Fuertes M.A., Castilla J., Alonso C., Quevedo C., and Pérez J.M. Biochemical mechanisms of cisplatin cytotoxicity. Anti-cancer Agents Med. Chem. 7 (2007) 3-18
10. Cullen K., Yang Z., Schumaker L., Zuhoski E., and Egorin M. Direct action on mitochondria, not nuclear DNA, mediates cisplatin induced apoptosis in head and neck cancer. Proc. Amer. Assoc. Cancer Res. 46 (2005) (abstract # 693)
11. Cullen K.J., Yang Z., Schumaker L., and Guo Z. Mitochondria as a critical target of the chemotherapeutic agent cisplatin in head and neck cancer. J. Bioenerg. Biomembr. 39 (2007) 43-50
12. Custódio J.B., Cardoso C.M., Santos M.S., Almeida L.M., Vicente J.A., and Fernandes M.A. Cisplatin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: prevention by thiol group protecting agents. Toxicology 259 (2009) 18-24
13. Devarajan P., Savoca M., Castaneda M.P., Park M.S., Esteban-Cruciani N., Kalinec G., and Kalinec F. Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways. Hearing Res. 174 (2002) 45-54
14. el Daly E.S. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J. Pharm. Belg. 53 (1998) 87-95
15. Estrela J.M., Hernandez R., Terradez P., Asensi M., Puertes I.R., and Vina J. Regulation of glutathione metabolism in Ehrlich ascites tumour cells. Biochem. J. 286 (1992) 257-262
16. Fillastre J.P., and Raguenez-Viotte G. Cisplatin nephrotoxicity. Toxicol. Lett. 46 (1989) 163-175
17. Fuertes M.A., Castilla J., Alonso C., and Perez J.M. Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr. Med. Chem. 10 (2003) 257-266
18. Garrido N., Pérez-Martos A., Faro M., Lou-Bonafonte J.M., Fernández-Silva P., Lopez-Pérez M.J., Montoya J., and Enriquez J.A. Cisplatin-mediated impairment of mitochondrial DNA metabolism inversely correlates with glutathione levels. Biochem. J. 414 (2008) 93-102
19. Go R.S., and Adjei A.A. Review of comparative pharmacology and clinical activity of cisplatin and carboplatin. J. Clin. Oncol. 17 (1999) 409-422
20. Gonzalez V.M., Fuertes M.A., Alonso C., and Perez J.M. Is cisplatin-induced cell death always produced by apoptosis?. Mol. Pharmacal. 59 (2001) 657-663
21. Gregg R.W., Molepo J.M., Monpetit V.J., Mikael N.Z., Redmond D., Gadia M., and Stewart D.J. Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J. Clin. Oncol. 10 (1992) 795-803
22. Heminger K.A., Hartson S.D., Rogers J., and Matts R.L. Cisplatin inhibits protein synthesis in rabbit reticulocyte lysate by causing an arrest in elongation. Arch. Biochem. Biophys. 344 (1997) 200-207
23. Ilbey Y.O., Ozbek E., Simsek A., Cekmen M., Otunctemur A., and Somay A. Chemopreventive effect of a nuclear factor-kB inhibitor, pyrrolidine dithiocarbamate, against cisplatin-induced testicular damage in rats. J. Androl. (2009) 10.2164/jandrol.108.006270
24. Ishikawa T., and Ali Osman F. Glutathione-associated cis-diamminedichloro platinum (II) metabolism and ATP-dependent efflux from leukemia cells; molecular characterization of glutathione platinum complex and its biological significance. J. Biol. Chem. 268 (1993) 20116-20125
25. Jones M.M., and Basinger M.A. Thiol and thioether suppression of cis-platinum induced nephrotoxicity in rats bearing the Walker 256 carcinoma. Anticancer Res. 9 (1989) 1937-1942
26. Jones T.W., Chopra S., Kaufman J.S., Flamenbaum W., and Trump B. Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations. Lab. Invest. 52 (1985) 363-374
27. Jones M.M., Basinger M.A., and Holscher M.A. Control of nephrotoxicity of cisplatin by clinically used sulfur-containing compounds. Fund. Appl. Toxicol. 18 (1992) 181-188
28. Kalkanis J.G., Whitworth C., and Rybak L.P. Vitamin E reduces cisplatin ototoxicity. Laryngoscope 114 (2004) 538-542
29. Kartalou M., and Essigmann J.M. Mechanisms of resistance to cisplatin. Mutat. Res. 478 (2001) 23-48
30. Khynriam D., and Prasad S.B. Hematotoxicity and blood glutathione levels after cisplatin treatment of tumor-bearing mice. Cell Biol. Toxicol. 17 (2001) 357-370
31. Khynriam D., and Prasad S.B. Changes in glutathione-related enzymes in tumor-bearing mice after cisplatin treatment. Cell Biol. Toxicol. 18 (2002) 349-358
32. King M.E. Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. In: Estabrook R.W., and Pullman M.E. (Eds). Methods in Enzymology vol. X (1967), New York, Academic Press 322-331
33. King M.E., Godman G.C., and King D.W. Respiratory enzymes and mitochondrial morphology of HeLa cells treated with chloramphenicol and ethidium bromide. J. Cell Biol. 53 (1972) 127-142
34. Kohn S., Fradis M., Pratt H., Zidan J., Podoshin L., Robinson E., and Nir I. Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis. Laryngoscope 98 (1988) 865-871
35. Kruidering M., Van de Water B., de Heer E., Mulder G.J., and Nagelkerke J.F. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J. Pharmacol. Exp. Ther. 280 (1997) 638-649
36. Le-Quoc K., and Le-Quoc D. Relationships between the NAD (P) redox state, fatty acid oxidation and inner membrane permeability in rat liver mitochondria. Arch. Biochem. Biophys. 273 (1989) 466-478
37. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
38. Lu Y., and Cederbaum A.I. Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicol. Sci. 89 (2006) 515-523
39. Luo J., Tsuji T., Yasuda H., Sun Y., Yoshihide Fujigaki Y., and Hishida A. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol. Dial. Transplant. 23 (2008) 2198-2205
40. Mariana G., Paik C.Y., Gaukler E.L., Diwan B.A., and Poirier M.C. Cisplatin exposure induces mitochondrial toxicity in pregnant rats and their fetuses. Reproduct. Toxicol. 15 (2001) 525-531
41. Martins N.M., Santos N.A.G., Curti C., Bianchi M.L.P., and Santos A.C. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J. Appl. Toxicol. 28 (2007) 337-344
42. Meister A., and Anderson M.E. Glutathione. Ann. Rev. Biochem. 52 (1983) 711-760
43. Mignotte B., and Vayssiere J. Mitochondria and apoptosis. Eur. J. Biochem. 252 (1998) 1-15
44. Murphy M.P., and Smith R.A.J. Drug delivery to mitochondria: the key to mitochondrial medicine. Adv. Drug Deliv. Rev. 41 (2000) 235-250
45. Naghizadeh B., Boroushaki M.T., Mashhadian N.V., and Mansouri S.M.T. Protective effects of crocin against cisplatin-induced acute renal failure and oxidative stress in rats. Iran. Biomed. J. 12 (2008) 93-100
46. Nair S.C., Salomi M.J., Panikkar B., and Panikkar K.R. Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in mice. J. Ethnopharmacol. 31 (1991) 75-83
47. 2+ ionophore-induced injury to isolated hepatocytes. Arch. Biochem. Biophys. 263 (1988) 226-235
48. Olivero O.A., Semino C., Kassim A., Lopez-Larraza D.M., and Poirier M.C. Preferential binding of cisplatin to mitochondrial DNA of Chinese hamster ovary cells. Mutat. Res. 346 (1995) 221-230
49. Olivero O.A., Chang P.K., Lopez-Larraza D.M., Semino-Mora M.C., and Poirrier M.C. Preferential formation and decreased removal of cisplatin DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA. Mutat. Res. 391 (1997) 79-86
50. Pace A., Savarese A., Picardo M., Maresca V., Pacetti U., Del Monte G., Biroccio A., Leonetti C., Jandolo B., Cognetti F., and Bove L. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J. Clin. Oncol. 21 (2003) 927-931
51. Pamplona R., Prat J., Cadenas S., Rojas C., Perez-Campo R., Lopez Torres M., and Barja G. Low fatty acid unsaturation protects against lipid peroxidation in liver mitochondria from long-lived species, the pigeon and human case. Mech. Aging Dev. 86 (1996) 53-66
52. Park M.S., De Leon M., and Devarajan P. Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J. Am. Soc. Nephrol. 13 (2002) 858-865
53. Pessayre D., Mansouri A., Haouzi D., and Fromenty B. Hepatotoxicity due to mitochondrial dysfunction. Cell Biol. Toxicol. 15 (1999) 367-373
54. Petit P.X., Le Cover H., Zorn H., Dauget C., Mignotte B., and Gougeon M.L. Alteration of mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130 (1995) 156-167
55. Prasad S.B., and Giri A. Antitumour effect of cisplatin against murine ascites Dalton's lymphoma. Ind. J. Exp. Biol. 32 (1994) 155-162
56. Prasad S.B., and Giri A. Cisplatin-induced changes in tissue calcium and potassium concentrations in tumor bearing mice. Med. Sci. Res. 27 (1999) 459-462
57. Prasad S.B., and Khynriam D. Mutagenicity and endogenous glutathione levels in tumor-bearing mice after cisplatin treatment. In: Khassanova L., Collery P., Maymard I., Khassanova Z., and Etienne J.C. (Eds). Metal Ions in Biology and Medicine vol 7 (2002), John Libbey Eurotext, Paris, France 580-585
58. Prasad S.B., Giri A., Khynriam D., Kharbangar A., Nicol B.M., and Lotha C. Cisplatin-mediated enzymatic changes in mice bearing ascites Dalton's lymphoma. Med. Sci. Res. 27 (1999) 723-730
59. Premkumar K., Thirunavukkarasu C., Abraham S.K., Santhiya S.T., and Ramesh A. Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-tumor agents in mice. Hum. Exp. Toxicol. 25 (2006) 79-84
60. Rao M., and Rao M.N. Effect of cisplatin on total protein in rat kidney cortical slices. Ind. J. Pharm. Sci. 60 (1998) 132-135
61. Ravi R., Somani S.M., and Rybak L.P. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol. Toxicol. 76 (1995) 386-394
62. Rosenberg B. Fundamental studies with cisplatin. Cancer 55 (1985) 2303-2316
63. Rosenberg J.M., and Sato P.H. Cisplatin inhibits in vitro translation by preventing the formation of complete initiation complex. Mol. Pharmacol. 43 (1993) 491-497
64. Schnellmann R.G., Gilchrist S.M., and Mandel L.J. Intracellular distribution and depletion of glutathione in rabbit renal proximal tubules. Kidney Int. 34 (1988) 229-233
65. Schwerdt G., Freudinger R., Schuster C., Weber F., Thews O., and Gekle M. Cisplatin-induced apoptosis is enhanced by hypoxia and by inhibition of mitochondria in renal collecting duct cells. Toxicol. Sci. 85 (2005) 735-742
66. Sedlak J., and Lindsay R.H. Estimation of total, protein-bound and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25 (1968) 192-205
67. Shan X., Jones D.P., Hashmi M., and Anders M.W. Selective depletion of mitochondrial glutathione concentrations by (R, S)-3-hydroxy-4-penetenoate potentiates oxidative cell death. Chem. Res. Toxicol. 6 (1993) 75-81
68. Shaw J.P., and Chou I.N. Elevation of intracellular glutathione content associated with mitogenic stimulation of quiescent fibroblasts. J. Cell Physiol. 129 (1986) 193-198
69. 2+ signalling and apoptosis. J. Bioenerg. Biomembr. 32 (2000) 35-46
70. Souid A.K., Tacka K.A., Galvan K.A., and Penefsky H.S. Immediate effects of anticancer drugs on mitochondrial oxygen consumption. Biochem. Pharmacol. 66 (2003) 977-987
71. Szatrowski T.P., and Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51 (1991) 794-798
72. Terradez P., Asensi M., Lasso de la Vega M.C., Puertes I., Vina J., and Estrela J.M. Depletion of tumor glutathione in vivo by buthionine sulfoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth. Biochem. J. 292 (1993) 477-483
73. Vladimirov Y.A., Olenev V.I., Suslova T.B., and Cheremisina Z.P. Lipid peroxidation in mitochondrial membrane. Adv. Lipid Res. 17 (1980) 173-249
74. Warburg O. On the origin of cancer of cells. Science 123 (1956) 309-314
75. White M.T., Ayra D.V., and Tewari K.K. Biochemical properties of neoplastic cell mitochondria. J. Natl. Cancer Inst. 53 (1974) 553-559
76. Yagi T., and Hatefi Y. Thiols in oxidative phosphorylation: inhibition and energy-potentiated uncoupling by monothiol and dithiol modifiers. Biochemistry 23 (1984) 2449-2455
77. Yanez J.A., Teng X.W., Roupe K.A., Fariss M.W., and Davies N.M. Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase-2. J. Pharm. Pharm. Sci. 6 (2003) 308-314
78. Yang Z., Schumaker L.M., Egorin M.J., Zuhowski E.G., Guo Z., and Cullen K.J. Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis. Clin. Cancer Res. 12 (2006) 5817-5825
79. Yao X., Panichpisal K., Neilkurtzman N., and Nugent K. Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. 334 (2007) 115-124
80. Zamble B.D., and Lippard S.J. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem. Sci. 20 (1995) 435-439
81. Zhang J.G., and Lindup W.E. Role of calcium in cisplatin induced cell toxicity in rat renal cortical slices. Toxicol. In Vitro 10 (1996) 205-209